State OH
Clinical Trials in Ohio
Recruiting clinical trials with at least one study location in Ohio. Data updated daily from ClinicalTrials.gov.
Top Conditions in Ohio
NCT06118567 Phase 2
Recruiting
Effect of Nitrous Oxide on Aggression.
Condition
Intermittent Explosive Disorder
Enrollment
50 pts
Location
United States
Sponsor
Ohio State University
NCT03523975 Phase 1, Phase 2
Recruiting
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Man...
Condition
Mantle Cell Lymphoma
Enrollment
28 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT05234567 N/A
Recruiting
A Prospective Sub-Study of the Global Hypophosphatasia Registry
Condition
Hypophosphatasia
Enrollment
30 pts
Location
United States
Sponsor
Alexion Pharmaceuticals, Inc.
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant S...
Condition
Cancer
Enrollment
110 pts
Location
United States, Australia, France
Sponsor
Alterome Therapeutics, Inc.
NCT05268341 N/A
Recruiting
Neuroimaging Reveals Treatment-related Changes in DLD
Condition
Developmental Language Disorder
Enrollment
184 pts
Location
United States
Sponsor
University of Cincinnati
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...
Condition
Alzheimer Disease
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT06106672 Phase 1, Phase 2
Recruiting
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in S...
Condition
Myasthenia Gravis
Enrollment
54 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
NCT05560477 Phase 1, Phase 2
Recruiting
Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing
Condition
Meniscus Tear
Enrollment
74 pts
Location
United States
Sponsor
University of Cincinnati
NCT04559230 Phase 2
Recruiting
Sacituzumab Govitecan in Recurrent Glioblastoma
Condition
Recurrent Glioblastoma
Enrollment
32 pts
Location
United States
Sponsor
The University of Texas Health
NCT06618612 N/A
Recruiting
A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellu...
Condition
Diabetic Foot Ulcer
Enrollment
170 pts
Location
United States
Sponsor
Organogenesis
NCT02407028 Phase 2
Recruiting
Hyperbaric Oxygen Brain Injury Treatment Trial
Condition
Traumatic Brain Injury
Enrollment
200 pts
Location
United States, Canada
Sponsor
Gaylan Rockswold
NCT06792695 Phase 2
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Color...
Condition
Metastatic Colorectal Cancer
Enrollment
120 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06937671 N/A
Recruiting
Randomized Trial of Cold EMR Compared to Hybrid Cold EMR.
Condition
Polyp of Colon
Enrollment
194 pts
Location
United States
Sponsor
The Cleveland Clinic
NCT05873712 Phase 2
Recruiting
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrom...
Condition
Recurrent Transformed Chronic Lymphocytic Leukemia
Enrollment
24 pts
Location
United States
Sponsor
Aseel Alsouqi
NCT01954992 Phase 3
Recruiting
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Condition
Metastatic Pancreatic Adenocarcinoma
Enrollment
480 pts
Location
United States
Sponsor
Eleison Pharmaceuticals LLC.
NCT04967989 Phase 3
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
Condition
Glaucoma and Ocular Hypertension
Enrollment
790 pts
Location
United States, Canada
Sponsor
University of Pittsburgh
NCT07148089 Phase 1
Recruiting
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tac...
Condition
Catecholaminergic Polymorphic Ventricular Tachycardia
Enrollment
18 pts
Location
United States, Canada
Sponsor
Solid Biosciences Inc.
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT07284186 Phase 1
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05140941 Phase 4
Recruiting
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
Condition
Hepatitis C, Chronic
Enrollment
100 pts
Location
United States, Canada
Sponsor
Catherine Anne Chappell
NCT06163326 Phase 3
Recruiting
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Partici...
Condition
Vitiligo
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Pfizer
NCT06149585 N/A
Recruiting
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Pl...
Condition
Edentulous Mouth
Enrollment
12 pts
Location
United States
Sponsor
Case Western Reserve Universit
NCT06440135 Phase 1
Recruiting
Ziftomenib Maintenance Post Allo-HCT
Condition
Acute Myeloid Leukemia
Enrollment
22 pts
Location
United States
Sponsor
Massachusetts General Hospital